Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between Different Polymorphic Markers and β-Thalassemia Intermedia in Central Iran.

Hemoglobin - 1 Jan 2020

Sajadpour Zahra, Amini-Farsani Zeinab, Motovali-Bashi Majid, Yadollahi Mitra, Khosravi-Farsani Nariman

Abstract excerpt

β-Thalassemia intermedia (β-TI) is a clinical condition characterized by moderate, non transfusional anemia and hepatosplenomegaly. The main objective of this study was to determine the molecular basis of the clinical phenotype of β-TI in Iran. To elucidate the mild phenotype of many patients with β-TI, we screened for three prevalent β-globin gene mutations [IVS-II-1 (G>A) HBB: c.315+1G>A, IVS-I-110 (G>A) HBB:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Globins
Share to Anemia, Hypochromic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to beta-Globins

Share to beta-Thalassemia

Share to Fetal Hemoglobin

Share to Hemoglobins, Abnormal

Share to Hepatomegaly

Share to Splenomegaly

Source

Identifiers

PMID: 31899996
DOI: 10.1080/03630269.2019.1709204

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between Different Polymorphic Markers and β-Thalassemia Intermedia in Central Iran.PMID 31899996Read ↗

Molecular basis of thalassemia intermedia in Iran.Semantic proximity Read ↗

Molecular Characterization of β-Thalassemia Intermedia in Southeast Iran.Semantic proximity Read ↗

Association between clinical expression and molecular heterogeneity in β-thalassemia Tunisian patients.Semantic proximity Read ↗

Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab Patients.Semantic proximity Read ↗

Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.Semantic proximity Read ↗

The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.Semantic proximity Read ↗

XmnI POLYMORPHISM AND DISEASE SEVERITY IN PATIENTS WITH BETA THALASSEMIA FROM NORTHERN PAKISTAN.Semantic proximity Read ↗

Genetic Epidemiology, Hematological and Clinical Features of Hemoglobinopathies in IranSemantic proximity Read ↗

Molecular mechanisms underlying thalassemia intermedia in Iran.Semantic proximity Read ↗

Effect of a group of genetic markers around the 5' regulatory regions of the β globin gene cluster linked to high HbF on the clinical severity of β thalassemia.Semantic proximity Read ↗

Identification of candidate genes involved in clinical variability among Tunisian patients with β-thalassemia.Semantic proximity Read ↗

Genetic factors affecting clinical severity in beta-thalassemia syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.